Income Statement - ARS Pharmaceuticals, Inc. (SPRY)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | |
|---|---|---|---|---|---|---|---|---|
| Total revenue | 84.28 | 89.15 | 0.03 | 1.32 | 5.51 | 17.84 | ||
| Cost of revenue | 20.42 | 20.56 | 0.07 | 17.12 | 0.21 | 14.07 | 1.55 | 1.42 |
| Gross profit | 63.86 | 68.59 | 0.03 | -15.80 | 5.29 | 3.77 | -1.55 | -1.42 |
| Total operating expenses | 243.30 | 71.68 | 67.55 | 19.71 | 24.75 | 4.23 | 22.52 | 16.90 |
| Operating income | -179.45 | -3.08 | -67.52 | -35.52 | -19.45 | -0.47 | -24.07 | -18.32 |
| Non-operating income (net) | 8.07 | 11.37 | 13.16 | 0.83 | -0.79 | -0.60 | 0.10 | 0.74 |
| Income before tax | -171.38 | 8.29 | -54.37 | -34.68 | -20.24 | -1.07 | -23.97 | -17.58 |
| Income tax expense | -0.08 | 0.29 | -0.09 | -0.69 | -0.23 | -0.20 | ||
| Net income | -171.30 | 8.00 | -54.37 | -34.68 | -20.24 | -1.07 | -23.97 | -17.58 |
Show Quarterly Income Statement
Income Statement - ARS Pharmaceuticals, Inc. (SPRY)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Jun-20 | Mar-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 22.68 | 28.09 | 32.50 | 15.72 | 7.97 | 86.58 | 2.07 | 0.50 | 0.00 | -0.03 | 0.00 | 0.01 | 0.02 | -1.32 | 0.19 | 0.46 | 0.66 | 0.75 | 0.53 | 2.11 | 2.11 | ||||
| Cost of revenue | 6.29 | 3.20 | 8.19 | 4.98 | 4.05 | 3.89 | 0.11 | 0.02 | 5.23 | 3.40 | 3.00 | 7.21 | 6.45 | 3.55 | 3.79 | 4.35 | 5.42 | 3.91 | 5.12 | 5.62 | 5.62 | 0.47 | 0.40 | 0.40 | 0.40 |
| Gross profit | 16.40 | 24.89 | 24.31 | 10.73 | 3.93 | 82.69 | 1.96 | 0.50 | -5.23 | -3.40 | -3.00 | -7.20 | -6.43 | -3.55 | -3.60 | -3.89 | -4.76 | -3.16 | -4.59 | -3.51 | -3.51 | -0.47 | -0.40 | -0.40 | -0.40 |
| Total operating expenses | 76.54 | 66.35 | 77.50 | 58.35 | 41.10 | 35.49 | 23.70 | 15.84 | 7.96 | 6.82 | 14.98 | 13.41 | 12.28 | 11.89 | 3.03 | 2.46 | 2.34 | 1.80 | 1.02 | 0.93 | 0.93 | 12.64 | 6.06 | 4.84 | 6.54 |
| Operating income | -60.15 | -41.47 | -53.19 | -47.61 | -37.18 | 47.20 | -21.75 | -15.34 | -13.19 | -10.23 | -17.98 | -20.60 | -18.71 | -15.44 | -6.63 | -6.34 | -7.10 | -4.96 | -5.62 | -4.44 | -4.44 | -13.10 | -6.46 | -5.24 | -6.93 |
| Non-operating income (net) | -0.47 | 0.06 | 2.04 | 2.73 | 3.24 | 3.03 | 2.62 | 2.82 | 2.90 | 3.06 | 3.11 | 3.23 | 3.75 | 1.01 | 0.05 | -0.08 | -0.15 | -0.18 | -0.19 | -0.21 | -0.21 | 0.02 | 0.00 | -0.04 | -0.04 |
| Income before tax | -60.62 | -41.40 | -51.15 | -44.88 | -33.94 | 50.22 | -19.13 | -12.52 | -10.29 | -7.17 | -14.87 | -17.37 | -14.96 | -14.43 | -6.58 | -6.42 | -7.25 | -5.14 | -5.81 | -4.65 | -4.65 | -13.09 | -6.47 | -5.28 | -6.97 |
| Income tax expense | -0.08 | 0.29 | -0.03 | 3.81 | -0.04 | -0.02 | -3.75 | 0.24 | -0.02 | -0.37 | 0.15 | ||||||||||||||
| Net income | -60.62 | -41.32 | -51.15 | -44.88 | -33.94 | 49.93 | -19.13 | -12.52 | -10.29 | -7.17 | -14.87 | -17.37 | -14.96 | -14.43 | -6.58 | -6.42 | -7.25 | -5.14 | -5.81 | -4.65 | -4.65 | -13.09 | -6.47 | -5.28 | -6.97 |